These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29253854)

  • 21. Secretion expression of human neutrophil peptide 1 (HNP1) in Pichia pastoris and its functional analysis against antibiotic-resistant Helicobacter pylori.
    Zhang X; Jiang A; Qi B; Yu H; Xiong Y; Zhou G; Qin M; Dou J; Wang J
    Appl Microbiol Biotechnol; 2018 Jun; 102(11):4817-4827. PubMed ID: 29675800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis.
    Khadem F; Jia P; Mou Z; Feiz Barazandeh A; Liu D; Keynan Y; Uzonna JE
    J Antimicrob Chemother; 2017 Feb; 72(2):467-477. PubMed ID: 27999013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A candidate vaccine composed of live nonpathogenic Iranian Lizard Leishmania mixed with Chitin microparticles protects mice against Leishmania major infection.
    Haghdoust S; Noroozbeygi M; Hajimollahoseini M; Masooleh MM; Yeganeh F
    Acta Trop; 2022 Mar; 227():106298. PubMed ID: 34971566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of negative air ions (NAIs) on Leishmania major: A novel tool for treatment of zoonotic cutaneous leishmaniasis (ZCL).
    Badirzadeh A; Najm M; Hemphill A; Alipour M; Hasanpour H; Masoori L; Karimi P
    PLoS One; 2022; 17(9):e0274124. PubMed ID: 36074764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. F₁ cross-breed between susceptible BALB/c and resistant Swiss mice infected with Leishmania major exhibit an intermediate phenotype for lesion sizes and type 1 cytokines but show low level of total IgG antibodies.
    Kiige SG; Mutiso JM; Laban LT; Khayeka-Wandabwa C; Anjili CO; Ingonga J; Gicheru MM
    Scand J Immunol; 2014 May; 79(5):283-91. PubMed ID: 24498914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanodisk-associated amphotericin B clears Leishmania major cutaneous infection in susceptible BALB/c mice.
    Nelson KG; Bishop JV; Ryan RO; Titus R
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1238-44. PubMed ID: 16569834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.
    Zadeh-Vakili A; Taheri T; Taslimi Y; Doustdari F; Salmanian AH; Rafati S
    Vaccine; 2004 May; 22(15-16):1930-40. PubMed ID: 15121305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model.
    Heidari-Kharaji M; Taheri T; Doroud D; Habibzadeh S; Rafati S
    Appl Microbiol Biotechnol; 2016 Aug; 100(16):7051-60. PubMed ID: 26960322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice model.
    Bolhassani A; Gholami E; Zahedifard F; Moradin N; Parsi P; Doustdari F; Seyed N; Papadopoulou B; Rafati S
    Exp Parasitol; 2011 May; 128(1):9-17. PubMed ID: 21276444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model.
    Katebi A; Gholami E; Taheri T; Zahedifard F; Habibzadeh S; Taslimi Y; Shokri F; Papadopoulou B; Kamhawi S; Valenzuela JG; Rafati S
    Mol Immunol; 2015 Oct; 67(2 Pt B):501-11. PubMed ID: 26298575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activities of naphthylisoquinoline alkaloids and synthetic analogs against Leishmania major.
    Ponte-Sucre A; Faber JH; Gulder T; Kajahn I; Pedersen SE; Schultheis M; Bringmann G; Moll H
    Antimicrob Agents Chemother; 2007 Jan; 51(1):188-94. PubMed ID: 17088484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro.
    Néris PL; Caldas JP; Rodrigues YK; Amorim FM; Leite JA; Rodrigues-Mascarenhas S; Barbosa-Filho JM; Rodrigues LC; Oliveira MR
    Exp Parasitol; 2013 Oct; 135(2):307-13. PubMed ID: 23891943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis.
    Abdian N; Gholami E; Zahedifard F; Safaee N; Rafati S
    Exp Parasitol; 2011 Mar; 127(3):627-36. PubMed ID: 21187087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Therapeutic Effects of Curcumin-coated Gold Nanoparticle Against Leishmania Major Causative Agent of Zoonotic Cutaneous Leishmaniasis (ZCL): An In Vitro and In Vivo Study.
    Amini SM; Hadighi R; Najm M; Alipour M; Hasanpour H; Vosoogh M; Vosough A; Hajizadeh M; Badirzadeh A
    Curr Microbiol; 2023 Feb; 80(4):104. PubMed ID: 36781499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of stable L. major(+EGFP-LUC) and simultaneous comparison between EGFP and luciferase sensitivity.
    Taheri T; Saberi Nik H; Seyed N; Doustdari F; Etemadzadeh MH; Torkashvand F; Rafati S
    Exp Parasitol; 2015 Mar; 150():44-55. PubMed ID: 25637784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system.
    Duarte MC; Lage LM; Lage DP; Martins VT; Carvalho AM; Roatt BM; Menezes-Souza D; Tavares CA; Alves RJ; Barichello JM; Coelho EA
    Parasitol Int; 2016 Dec; 65(6 Pt A):728-736. PubMed ID: 27425599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-Adrenergic blockade protects BALB/c mice against infection with a small inoculum of Leishmania mexicana mexicana (LV4).
    García-Miss Mdel R; Mut-Martín MC; Góngora-Alfaro JL
    Int Immunopharmacol; 2015 Jan; 24(1):59-67. PubMed ID: 25461918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials.
    Zahedifard F; Lee H; No JH; Salimi M; Seyed N; Asoodeh A; Rafati S
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007217. PubMed ID: 30811391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
    J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulatory properties of borage (Echium amoenum) on BALB/c mice infected with Leishmania major.
    Hosseini N; Abolhassani M
    J Clin Immunol; 2011 Jun; 31(3):465-71. PubMed ID: 21225450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.